237 related articles for article (PubMed ID: 21062352)
1. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model.
Jung-Hynes B; Schmit TL; Reagan-Shaw SR; Siddiqui IA; Mukhtar H; Ahmad N
J Pineal Res; 2011 Mar; 50(2):140-9. PubMed ID: 21062352
[TBL] [Abstract][Full Text] [Related]
2. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells.
Jung-Hynes B; Huang W; Reiter RJ; Ahmad N
J Pineal Res; 2010 Aug; 49(1):60-8. PubMed ID: 20524973
[TBL] [Abstract][Full Text] [Related]
3. IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.
Mayo JC; Hevia D; Quiros-Gonzalez I; Rodriguez-Garcia A; Gonzalez-Menendez P; Cepas V; Gonzalez-Pola I; Sainz RM
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736013
[TBL] [Abstract][Full Text] [Related]
4. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?
Jung-Hynes B; Nihal M; Zhong W; Ahmad N
J Biol Chem; 2009 Feb; 284(6):3823-32. PubMed ID: 19075016
[TBL] [Abstract][Full Text] [Related]
5. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
Shukla S; MacLennan GT; Fu P; Gupta S
Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
[TBL] [Abstract][Full Text] [Related]
6. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of androgen-sensitive LNCaP prostate cancer growth in vivo by melatonin: association of antiproliferative action of the pineal hormone with mt1 receptor protein expression.
Xi SC; Siu SW; Fong SW; Shiu SY
Prostate; 2001 Jan; 46(1):52-61. PubMed ID: 11170132
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
[TBL] [Abstract][Full Text] [Related]
12. Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.
Ge D; Dauchy RT; Liu S; Zhang Q; Mao L; Dauchy EM; Blask DE; Hill SM; Rowan BG; Brainard GC; Hanifin JP; Cecil KS; Xiong Z; Myers L; You Z
J Pineal Res; 2013 Nov; 55(4):377-87. PubMed ID: 24033914
[TBL] [Abstract][Full Text] [Related]
13. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
[TBL] [Abstract][Full Text] [Related]
14. Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.
Xu H; Jiang HW; Ding Q
Actas Urol Esp; 2015 Apr; 39(3):161-8. PubMed ID: 25442907
[TBL] [Abstract][Full Text] [Related]
15. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
Sharma G; Singh RP; Agarwal R
Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
[TBL] [Abstract][Full Text] [Related]
17. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of melatonin on human prostate cancer.
Shen D; Ju L; Zhou F; Yu M; Ma H; Zhang Y; Liu T; Xiao Y; Wang X; Qian K
Cell Commun Signal; 2021 Mar; 19(1):34. PubMed ID: 33722247
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells.
Jung-Hynes B; Ahmad N
Cell Cycle; 2009 May; 8(10):1478-83. PubMed ID: 19377286
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells.
Peng L; Malloy PJ; Wang J; Feldman D
Endocrinology; 2006 Oct; 147(10):4599-607. PubMed ID: 16825320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
